Getting approved for Ozempic involves two separate hurdles: qualifying medically and getting your insurance to cover it. Ozempic (semaglutide) is FDA-approved specifically for adults with type 2 diabetes, so your path to approval starts with that diagnosis. Here’s what the full process looks like, from your doctor’s office to your pharmacy counter.
Who Qualifies for Ozempic
Ozempic has two FDA-approved uses: improving blood sugar control in adults with type 2 diabetes (alongside diet and exercise), and reducing the risk of heart attack, stroke, or cardiovascular death in adults who have both type 2 diabetes and established heart disease. That’s it. It is not approved for type 1 diabetes, and it is not the same as Wegovy, which is the semaglutide product approved specifically for weight loss.
To be diagnosed with type 2 diabetes, your A1C level (a measure of average blood sugar over about three months) needs to be 6.5% or higher. If you already carry a type 2 diabetes diagnosis and your blood sugar isn’t well controlled with your current treatment plan, you’re a strong candidate. Many doctors prescribe Ozempic when lifestyle changes alone or first-line medications haven’t brought A1C levels into a healthy range.
Some people seek Ozempic primarily for weight loss. While semaglutide does cause significant weight loss, doctors who prescribe Ozempic off-label for that purpose face a different insurance landscape. The weight-loss version, Wegovy, has its own approval criteria: a BMI over 30, or a BMI over 27 with at least one weight-related condition like high blood pressure or sleep apnea. If weight management is your main goal and you don’t have type 2 diabetes, ask your doctor whether Wegovy is the better route.
Who Cannot Take Ozempic
Certain medical histories will disqualify you entirely. Ozempic is contraindicated if you or a close family member has had medullary thyroid carcinoma (a specific type of thyroid cancer) or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). These are hard stops, not judgment calls.
If you have a history of pancreatitis, your doctor will likely steer you toward a different diabetes medication. Ozempic has not been studied in people with prior pancreatitis, and the drug carries a warning about pancreatic inflammation. A history of severe kidney disease or diabetic retinopathy doesn’t automatically rule you out, but your doctor will want to monitor those conditions more closely if you start treatment.
What Happens at Your Doctor’s Visit
There’s no single blood test that “unlocks” an Ozempic prescription. Your doctor will review your diabetes diagnosis, your current A1C, and what treatments you’ve already tried. If you’re a new patient or haven’t had recent labs, expect bloodwork to check your blood sugar levels, kidney function, and general metabolic health.
Your doctor will also ask about your full medical history, including thyroid conditions, pancreatic problems, and any history of diabetic eye disease. If you have diabetic retinopathy, your provider may want an eye exam on record before starting treatment, since rapid improvements in blood sugar can temporarily worsen certain eye conditions. Once your doctor determines you’re a good candidate, they’ll write the prescription and, in most cases, start the prior authorization process with your insurance.
Getting Insurance to Cover It
This is where many people hit a wall. Ozempic costs over $900 per month without insurance, so coverage matters. Most commercial insurance plans and Medicare Part D plans require prior authorization before they’ll pay for it. That means your doctor’s office submits paperwork proving you meet the plan’s criteria, and the insurer reviews it before approving or denying the claim.
What insurers typically want to see varies by plan, but common requirements include:
- A confirmed type 2 diabetes diagnosis with recent A1C results
- Documentation of previous treatments, such as metformin or other first-line diabetes drugs that didn’t adequately control your blood sugar (this is called “step therapy”)
- Evidence that lifestyle modifications like diet and exercise have been attempted
Some plans are stricter than others. A few require you to have tried and failed two or more other diabetes medications before they’ll approve a GLP-1 drug like Ozempic. Others approve it more readily if your A1C is above a certain threshold. Coverage is typically approved for one year at a time, after which your doctor will need to submit for reauthorization with updated lab results showing the medication is working.
If your prior authorization is denied, you have options. Your doctor can file an appeal with additional clinical documentation. Many insurance companies also have a peer-to-peer review process where your doctor speaks directly with the plan’s medical reviewer to make the case. These appeals succeed more often than people expect, especially when the documentation clearly shows other medications haven’t worked.
If You Don’t Have Insurance Coverage
If your plan excludes GLP-1 medications or you’re uninsured, the out-of-pocket cost is steep. Novo Nordisk (Ozempic’s manufacturer) offers savings programs for commercially insured patients that can reduce copays, but these don’t apply to government insurance like Medicare or Medicaid. Some patients work with their doctors to explore manufacturer patient assistance programs, which provide the drug at reduced cost or free to people who meet income requirements.
The supply picture has improved significantly. Ozempic was on the FDA’s drug shortage list from 2022 through early 2025 due to surging demand, which made it difficult for even approved patients to fill prescriptions. As of February 2025, the FDA confirmed that the shortage is resolved and the manufacturer’s production capacity can meet current and projected demand. This means fewer pharmacy delays once you do have a prescription in hand.
What to Expect After Approval
Once approved, you’ll start on the lowest dose and gradually increase over several weeks. Your doctor will schedule follow-up labs, typically an A1C test at least twice a year, to confirm the drug is bringing your blood sugar into range. Kidney function tests and monitoring for side effects like nausea or gastrointestinal issues are also part of ongoing care.
If your A1C improves and you tolerate the medication well, reauthorization at the one-year mark is usually straightforward. Your doctor submits updated labs showing the drug is doing its job, and the insurer renews coverage. The key to a smooth process, both initially and at renewal, is having clear documentation: recent bloodwork, a record of previous treatments, and notes showing the clinical rationale for Ozempic specifically.